Abstract

The end timing of T waves in fetal electrocardiogram (fECG) is important for the evaluation of ST and QT intervals which are vital markers to assess cardiac repolarization patterns. Monitoring malignant fetal arrhythmias in utero is fundamental to care in congenital heart anomalies preventing perinatal death. Currently, reliable detection of end of T waves is possible only by using fetal scalp ECG (fsECG) and fetal magnetocardiography (fMCG). fMCG is expensive and less accessible and fsECG is an invasive technique available only during intrapartum period. Another safer and affordable alternative is the non-invasive fECG (nfECG) which can provide similar assessment provided by fsECG and fMECG but with less accuracy (not beat by beat). Detection of T waves using nfECG is challenging because of their low amplitudes and high noise. In this study, a novel model-based method that estimates the end of T waves in nfECG signals is proposed. The repolarization phase has been modeled as the discharging phase of a capacitor. To test the model, fECG signals were collected from 58 pregnant women (age: (34 ± 6) years old) bearing normal and abnormal fetuses with gestational age (GA) 20-41 weeks. QT and QTc intervals have been calculated to test the level of agreement between the model-based and reference values (fsECG and Doppler Ultrasound (DUS) signals) in normal subjects. The results of the test showed high agreement between model-based and reference values (difference < 5%), which implies that the proposed model could be an alternative method to detect the end of T waves in nfECG signals.

Highlights

  • Many heart defects and complications start developing during the prenatal period [1, 2]

  • Only periods that had visible T waves in fetal scalp ECG (fsECG) records or visible aortic closing (Ac) in Doppler Ultrasound (DUS) records have been considered in this study

  • End of T waves are important for QT estimation which are biomarkers for many cardiac complications including sudden cardiac death

Read more

Summary

Introduction

Many heart defects and complications start developing during the prenatal period [1, 2]. It is estimated that around 1 out of 125 babies develop congenital heart defects before their birth [1]. Some of the born babies may suffer from minor heart defects that go undiagnosed for years [1]. Intrauterine growth restriction (IUGR), which affects around 3%— 10% of pregnant women, has been associated with several cardiovascular diseases that develop during adulthood [2]. To reduce the number of cardiovascular complications, fetal heart rate (fHR) monitoring has grown to be a vital procedure for pregnant women [3]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call